These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9200342)
21. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573 [TBL] [Abstract][Full Text] [Related]
22. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
23. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk]. Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287 [TBL] [Abstract][Full Text] [Related]
25. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulant therapy in pregnant women with mechanical heart valves. Leyh RT; Fischer S; Ruhparwar A; Haverich A Arch Gynecol Obstet; 2003 Apr; 268(1):1-4. PubMed ID: 12673466 [TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. Harenberg J; Weuster B; Pfitzer M; Dempfle CE; Stehle G; Kübler W; Schlierf G Semin Thromb Hemost; 1993; 19 Suppl 1():116-21. PubMed ID: 8395713 [TBL] [Abstract][Full Text] [Related]
29. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]
30. Prevention of perioperative thromboembolism in patients with atrial fibrillation. Beldi G; Beng L; Siegel G; Bisch-Knaden S; Candinas D Br J Surg; 2007 Nov; 94(11):1351-5. PubMed ID: 17631677 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of venous thrombosis in cancer patients: practical aspects]. Laza-Achille M; Desruennes E; Di Palma M Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314 [TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369 [TBL] [Abstract][Full Text] [Related]
33. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615 [TBL] [Abstract][Full Text] [Related]
34. Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism. Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Ciccarese M; Papaldo P; Fabi A; Cognetti F Thromb Res; 2007; 119(4):525-9. PubMed ID: 16780933 [TBL] [Abstract][Full Text] [Related]
35. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy. Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594 [TBL] [Abstract][Full Text] [Related]
36. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063 [TBL] [Abstract][Full Text] [Related]
37. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses]. Gohlke-Bärwolf C Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813 [TBL] [Abstract][Full Text] [Related]
38. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. Torn M; van der Meer FJ; Rosendaal FR Arch Intern Med; 2004 Mar; 164(6):668-73. PubMed ID: 15037497 [TBL] [Abstract][Full Text] [Related]
39. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation. Verma A; Tsang B Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378 [TBL] [Abstract][Full Text] [Related]